447 / 1816
Key issues
•
Oncoplastic options offered to all patients requiring mastectomy
•
MDT discussion of all cases
•
Training and CPD requirements
•
Rates of implant loss less than 5%: Antibiotic use specified
•
Regular audit
•
Patient reported outcomes audited